Fidabio
Exhibition Partner
Fidabio's Flow-Induced Dispersion Analysis (FIDA) provides precise in-solution measurements of binding affinity, kinetics, quantity, and quality, critical for studying molecular glues. FIDA delivers 10 biophysical parameters in one assay using minimal sample volumes (nL-µL). This robust technology ensures reproducible data in complex matrices without clogging or maintenance issues. Streamlining workflows across drug discovery and research, FIDA offers unmatched precision, reliability, and versatility for advancing molecular glue insights. Visit fidabio.com.
Hybrigenics Services
Event Partner
Hybrigenics Services leverages over 25 years of expertise in optimized Y2H technology to offer a robust molecular glue screening platform. Our Y2Hchem system identifies novel chemically-induced protein-protein interactions or drugs that stabilize these interactions, offering human tissue and tumor cell libraries for screening. Additionally, our animal-free Hybribody™ platform utilizes phage display to select for nanobodies or intrabodies that recognize conformational epitopes. Our services have resulted in over 600 scientific publications authored by our clients.
Collaborative Drug Discovery (CDD)
Event Partner
Collaborative Drug Discovery (CDD) provides an intuitive software suite extensively used by creative biologists and chemists working in academic, biotechnology and pharmaceutical settings. Their flagship product, CDD Vault, enables researchers to intuitively organize and analyze both biological and chemical data, and to collaborate with partners through a straightforward web interface. CDD Vault helps scientists register entities, track inventory, manage bioassay data, capture experiments, calculate Structure-Activity Relationships (SAR), and mine their data for drug candidates. It also functions as an Electronic Laboratory Notebook (ELN) to capture and share experimental results. CDD Vault is differentiated through its intuitive design, superior performance, and workflows for secure, collaborative data sharing capabilities. CDD was founded in 2004 and presently serves thousands of researchers doing drug discovery all around the world. Learn more at www.collaborativedrug.com
Curia Global
Event Partner
Curia is a global Contract Development and Manufacturing Organization with over 30 years of experience successfully guiding clients through the complexities of drug discovery, development, and manufacturing to make treatments broadly accessible to patients. Our Small Molecules offering spans discovery to commercial manufacturing and fill-finish services, integrating scientific, process, regulatory and analytical capabilities. Curia’s scalable technologies and dedicated teams advance your program through drug substance and drug product manufacturing.
From curiosity to cure, we are your trusted ally to accelerate life-changing therapeutics.
Learn more at www.curiaglobal.com
